Elanco Animal Health Incorporated (ELAN) Stock Price & Analysis
Market: NYSE • Sector: Healthcare • Industry: Drug Manufacturers - Specialty & Generic
Elanco Animal Health Incorporated (ELAN) Profile & Business Summary
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Key Information
| Ticker | ELAN |
|---|---|
| Exchange | NYSE |
| Official Site | https://www.elanco.com |
Market Trend Overview for ELAN
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-07-13 (ET)
As of 2026-07-13, ELAN is moving sideways with low volatility. Over the longer term, the trend remains bullish.
ELAN last closed at 25.14. The price is about 0.9 ATR above its recent average price (24.24), and the market is currently in a sideways market with low volatility. Price at 25.14 is moving between minor support near 23.76 and minor resistance near 26.23. Direction remains unclear. View Support & Resistance from Options
Price is moving in a tight range. This often leads to a stronger move once the range breaks, increasing one-sided risk.
Trend score: 40 out of 100. Overall alignment is unclear. The market is currently in a sideways phase with tightening price movement. The longer-term trend is still positive, but short-term signals are not yet confirming it.
A key downside risk boundary is near 22.33. If price falls below this area, the current structure would likely weaken further.
On 2026-06-17, trend conditions deteriorated, suggesting that moves in the prior direction became less dependable.
[2026-07-13] Price moved quickly and looked strong, but participation was limited.Bearish signal near resistance (0.05 ATR away). Reversal risk is higher. Pattern is less clear, so strength is reduced.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
Some late-day positioning was observed, but it lacked strong overnight commitment.
The model sees a bullish edge, with 57.2% upside probability and a still-actionable balance between confirmation and reversal risk.
Up probability is 57.2%, with predictability at 51% and signal agreement at 88%. Reversal risk is 17%. That suggests the directional case is supported by broad confirmation and still retains usable quality.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This reading is based on the last 20 trading days of 15-minute price, volume, and VWAP data. Price is modestly above the recent estimated cost basis of 24.52, so the recent structure is still on the firmer side. Price is above the main cost band (24.53 to 24.91), and about 97% of recent positioning is already in profit. That supports trend strength, but it also raises the chance of profit-taking if momentum cools. The nearby support area sits around 24.07 to 25.14, and it looks fairly solid right now. The main cost band is fairly wide relative to recent ATR, so this structure may behave less cleanly than a tighter setup. From a trading point of view, the trend still has support. The main question is whether pullbacks stay orderly above or near 24.07 to 25.14.